Latin America Western Blotting Market Forecast Analysis 2024-2032
Triton’s research report estimates that the Latin America western blotting market is expected to garner revenue at a CAGR of 5.21% during the forecast years 2024-2032.
As per PAHO, the rise in new HIV infections in Latin America, with a 9% increase from 2010 to 2023 and approximately 120,000 new cases in 2023, has driven a heightened demand for accurate and reliable diagnostic tools. Western blotting techniques, widely used for confirming HIV diagnoses after initial screening tests, play a crucial role in the detection of HIV proteins and antibodies. As the need for precise diagnosis grows, healthcare providers increasingly rely on western blotting to ensure early and accurate detection. This growing use has spurred the expansion of the western blotting market in this region, as both public health initiatives and private healthcare systems invest in advanced diagnostic solutions.
The countries studied in this region include Brazil, Mexico, and Rest of Latin America.
Brazil captured the highest share in the western blotting market, obtaining about $10.27 million in 2023.
- As per industry data, Brazil has an estimated 960,000 people diagnosed with HIV, necessitating advanced diagnostic techniques like western blotting for accurate detection and monitoring.
- This has resulted in active efforts by the government to enhance healthcare infrastructure, along with increased funding for research and diagnostic testing, which have created favorable conditions for the expansion of the western blotting market.
- Additionally, an increase in research and development activities within the biotechnology sector, focusing on areas such as proteomics and molecular biology, has fueled demand for western blotting techniques.
Western Blotting Market Forecast for Mexico
Western blotting is a crucial diagnostic tool used in confirming HIV infections, leading to its increased adoption in medical diagnostics and research facilities. The country’s expanding biotechnology and pharmaceutical sectors, coupled with increased investment in R&D, have boosted the need for advanced protein analysis techniques like western blotting. NIH states that, in Mexico, approximately 340,000 people are currently living with HIV, including more than 40,000 residing in Mexico City. This number highlights the importance of diagnostic tools such as western blotting in disease management and research, thereby widening the scope of western blotting techniques.
The western blotting market is segmented based on product type, application, and end-user. Based on application, it is further classified into agriculture, disease diagnostics, biomedical & biochemical research, and other applications. In agriculture, western blotting is commonly used to confirm ELISA test results, especially when the outcome can significantly impact the agricultural community. For instance, a positive ELISA test for bovine spongiform encephalopathy (mad cow disease) may be verified through Western blotting, as a false positive could have disastrous effects on a nation’s cattle trade.
Contender Analysis in the Western Blotting Market:
Founded in 2005, Advansta specializes in developing innovative protein characterization technologies designed for simplicity, superior performance, and faster life science research. The company strives to be a leading provider of protein characterization products. Its WesternBright line of substrates enhances protein analysis, with flagship products recognized as the most sensitive chemiluminescent substrates available on the market. It is headquartered in San Jose, California.
The company provides several types of products under Fluorescent Western blotting, Electrophoresis, Antibodies and Antibody Labeling, etc. Some of them include WesternBright ChemiPen, AdvanStain Total Fluorescent Protein Staining Kits, FLASHBlot transfer buffer, LightSaver Fluorescence Enhancing Solution, etc.
The key entities in the reviewed market are Merck KGaA, Thermo Fisher Scientific, Enzo Biochem Inc, Geno Technology Inc, Bio-Rad Technologies, and Stressmarq Biosciences Inc.